Recent Quarter Total Invested
$2.07 B
Recent Quarter Institutional Ownership Percentage
83.49%
Total Invested of Last Quarter
$1.87 B
Ownership Percentage of Last Quarter
82.07%
Janux Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 9.17 M | $416.40 M | 0.00% | 16.78% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 2.52 M | $114.59 M | 40.05% | 4.62% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.42 M | $110.06 M | 100.00% | 4.43% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 2.40 M | $109.06 M | 53.45% | 4.39% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 2.08 M | $94.27 M | -10.86% | 3.80% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.60 M | $72.70 M | 431.96% | 2.93% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 1.47 M | $66.77 M | 0.00% | 2.69% |
| STATE STREET CORP | 11/14/2024 | 1.36 M | $61.84 M | -2.86% | 2.49% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 1.26 M | $57.18 M | -57.76% | 2.30% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 1.05 M | $47.70 M | 0.00% | 1.92% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.01 M | $45.87 M | -35.15% | 1.85% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 1.00 M | $45.43 M | 33.33% | 1.83% |
| LORD, ABBETT & CO. LLC | 11/14/2024 | 703,481 | $31.96 M | 0.12% | 1.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 662,594 | $30.11 M | 6.17% | 1.21% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 562,000 | $25.53 M | -33.11% | 1.03% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 485,000 | $22.03 M | -33.10% | 0.89% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 10/21/2024 | 471,736 | $21.43 M | 100.00% | 0.86% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 395,875 | $17.98 M | 190.17% | 0.72% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 365,200 | $16.59 M | 100.00% | 0.67% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 315,735 | $14.34 M | -8.40% | 0.58% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 234,191 | $10.64 M | 202.12% | 0.43% |
| PROSIGHT MANAGEMENT, LP | 11/14/2024 | 205,000 | $9.31 M | 100.00% | 0.38% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 203,184 | $9.23 M | 1.91% | 0.37% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 190,000 | $8.63 M | 280.00% | 0.35% |
| BARCLAYS PLC | 11/19/2024 | 174,061 | $7.91 M | 496.55% | 0.32% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 171,105 | $7.77 M | 100.00% | 0.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 166,892 | $7.58 M | -57.95% | 0.31% |
| SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 164,770 | $7.49 B | 100.00% | 0.30% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 159,421 | $7.24 M | -36.83% | 0.29% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 149,355 | $6.79 M | -38.42% | 0.27% |
| MORGAN STANLEY | 11/14/2024 | 140,464 | $6.38 M | 71.72% | 0.26% |
| CANDRIAM S.C.A. | 11/13/2024 | 137,105 | $6.23 M | 22.41% | 0.25% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 133,000 | $6.04 M | 0.00% | 0.24% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 123,658 | $5.62 M | 100.00% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 119,000 | $5.41 M | 73.98% | 0.22% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 108,811 | $4.94 M | 100.00% | 0.20% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 106,847 | $4.85 M | 0.00% | 0.20% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 106,500 | $4.84 M | 100.00% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 86,835 | $3.94 M | -24.51% | 0.16% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 83,989 | $3.82 M | -14.14% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 80,000 | $3.63 M | 45.45% | 0.15% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 80,000 | $3.63 M | 100.00% | 0.15% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 77,192 | $3.51 M | -25.49% | 0.14% |
| MACQUARIE GROUP LTD | 11/14/2024 | 76,601 | $3.48 M | 0.00% | 0.14% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 74,273 | $3.44 M | 111.12% | 0.14% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 69,801 | $3.17 M | 15.23% | 0.13% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 65,690 | $2.98 M | -14.96% | 0.12% |
| E FUND MANAGEMENT CO., LTD. | 11/13/2024 | 65,098 | $2.96 M | 100.00% | 0.12% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 63,215 | $2.87 M | 100.00% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 62,799 | $2.85 M | -47.40% | 0.12% |
Janux Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of JANX shares?
During the previous two years, 178 institutional investors and hedge funds held shares of Janux Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 9.17 M
JANUS HENDERSON GROUP PLC: 2.52 M
BlackRock Funding, Inc. /DE: 2.42 M
Paradigm Biocapital Advisors LP: 2.4 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.08 M
Woodline Partners LP: 1.6 M
-
What percentage of Janux Therapeutics, Inc. stock is owned by institutional investors?
83.49% of Janux Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at JANX ?
Institutional investors have bought a total of 38.11 M shares in the last 24 months. This purchase volume represents approximately $1.81 B in transactions.